vs
布鲁克菲尔德资产管理（BAM）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
布鲁克菲尔德资产管理的季度营收约是Royalty Pharma plc的1.7倍（$1.1B vs $622.0M），布鲁克菲尔德资产管理净利率更高（56.7% vs 34.4%，领先22.2%）
布鲁克菲尔德资产管理有限公司是加美两地的另类资产管理机构，2022年12月从布鲁克菲尔德集团的资管业务分拆成立，在全球范围内管理不动产、基础设施、可再生能源、私募股权及信贷市场等领域的投资。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BAM vs RPRX — 直观对比
营收规模更大
BAM
是对方的1.7倍
$622.0M
净利率更高
BAM
高出22.2%
34.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $615.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 84.2% | 62.4% |
| 净利率 | 56.7% | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BAMRPRX
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $974.0M | $609.3M | ||
| Q2 25 | $931.0M | $578.7M | ||
| Q1 25 | $954.0M | $568.2M | ||
| Q4 24 | — | $593.6M | ||
| Q3 24 | $873.0M | $564.7M | ||
| Q2 24 | $821.0M | $537.3M | ||
| Q1 24 | $786.0M | $568.0M |
净利润BAMRPRX
| Q4 25 | $615.0M | $214.2M | ||
| Q3 25 | $692.0M | $288.2M | ||
| Q2 25 | $584.0M | $30.2M | ||
| Q1 25 | $507.0M | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | $537.0M | $544.0M | ||
| Q2 24 | $124.0M | $102.0M | ||
| Q1 24 | $373.0M | $4.8M |
营业利润率BAMRPRX
| Q4 25 | 84.2% | 62.4% | ||
| Q3 25 | 79.1% | 70.1% | ||
| Q2 25 | 70.8% | 36.3% | ||
| Q1 25 | 61.0% | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | 72.5% | — | ||
| Q2 24 | 80.4% | 50.2% | ||
| Q1 24 | 56.5% | -13.0% |
净利率BAMRPRX
| Q4 25 | 56.7% | 34.4% | ||
| Q3 25 | 71.0% | 47.3% | ||
| Q2 25 | 62.7% | 5.2% | ||
| Q1 25 | 53.1% | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | 61.5% | 96.3% | ||
| Q2 24 | 15.1% | 19.0% | ||
| Q1 24 | 47.5% | 0.8% |
每股收益（稀释后）BAMRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $8.9B | $9.7B |
| 总资产 | $17.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BAMRPRX
| Q4 25 | $1.6B | $618.7M | ||
| Q3 25 | $1.1B | $938.9M | ||
| Q2 25 | $480.0M | $631.9M | ||
| Q1 25 | $332.0M | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | $10.0M | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务BAMRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益BAMRPRX
| Q4 25 | $8.9B | $9.7B | ||
| Q3 25 | $8.5B | $9.6B | ||
| Q2 25 | $8.5B | $9.5B | ||
| Q1 25 | $8.5B | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | $9.0B | $10.3B | ||
| Q2 24 | $3.2B | $9.8B | ||
| Q1 24 | $2.2B | $9.9B |
总资产BAMRPRX
| Q4 25 | $17.0B | $19.6B | ||
| Q3 25 | $16.5B | $19.3B | ||
| Q2 25 | $16.1B | $18.3B | ||
| Q1 25 | $15.0B | $17.6B | ||
| Q4 24 | — | $18.2B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | $4.2B | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比BAMRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $562.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.91× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BAMRPRX
| Q4 25 | $562.0M | $827.1M | ||
| Q3 25 | $745.0M | $702.6M | ||
| Q2 25 | $529.0M | $364.0M | ||
| Q1 25 | $265.0M | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | $567.0M | $703.6M | ||
| Q2 24 | $159.0M | $658.2M | ||
| Q1 24 | $516.0M | $664.6M |
现金转化率BAMRPRX
| Q4 25 | 0.91× | 3.86× | ||
| Q3 25 | 1.08× | 2.44× | ||
| Q2 25 | 0.91× | 12.06× | ||
| Q1 25 | 0.52× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 1.06× | 1.29× | ||
| Q2 24 | 1.28× | 6.45× | ||
| Q1 24 | 1.38× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BAM
| Incentive Fees | $452.0M | 42% |
| Infrastruture | $332.0M | 31% |
| Private Equity | $174.0M | 16% |
| Renewable Power And Transition | $66.0M | 6% |
| Other | $47.0M | 4% |
| Management And Advisory Fees | $14.0M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
